Login Get Started
Browse
Shares
Healthcare
Pharmaceuticals
Jenburkt Pharmaceuticals
Jenburkt Pharmaceuticals logo

524731 - Jenburkt Pharmaceuticals Reuters News

₹413.9 12.7  3.2%

Last Trade - 7:06am

Sector
Healthcare
RiskRating
Adventurous
Size
Micro Cap
Style
Contrarian
Market Cap £18.4m
Enterprise Value £11.8m
Revenue £11.2m
Position in Universe 1397th / 3045
Quality
Value
Momentum
StockRank™
StockReport™
Tools
Compare with... Run through checklist
Accounts
Balance sheet Income statement Cashflow statement Dividend summary
Charts News Discussions 524731 Dividends
Reuters News
All News Reuters News Company Announcements
Cipla gets India approval to sell COVID-19 drug favipiravir
24th Jul '20 News
BRIEF-Jenburkt Pharma To Launch Favipiravir-200mg Tablet Under Trade Name Favivent
24th Jul '20 News
BRIEF-Jenburkt Pharmaceuticals Plans To Launch Favipiravir-200 Mg Tablets
21st Jul '20 News
BRIEF-India's Jenburkt Pharmaceuticals June-Qtr PAT Falls
30th Jul '19 News
BRIEF-India's Jenburkt Pharma Dec-Qtr Profit Falls
5th Feb '19 News
BRIEF-India's Jenburkt Pharmaceuticals Sept-Qtr PAT Falls
30th Oct '18 News
BRIEF-India's Jenburkt Pharmaceuticals Posts June-Qtr PAT
31st Jul '18 News
BRIEF-India's Jenburkt Pharma March Qtr Profit Rises
29th May '18 News
BRIEF-Jenburkt Pharmaceuticals ‍Declares Interim Dividend Of 3 Rupees/Shr
20th Mar '18 News
BRIEF-India's Jenburkt Pharma Dec Qtr Profit Rises
9th Feb '18 News
BRIEF-India's Jenburkt Pharmaceuticals Sept Qtr Profit Rises
5th Dec '17 News
BRIEF-Jenburkt Pharmaceuticals gets shareholders' nod for share buyback
27th Oct '17 News
BRIEF-Jenburkt Pharmaceuticals says to consider matters related to buyback
5th Sep '17 News
BRIEF-India's Jenburkt Pharmaceuticals posts June-qtr loss
30th Aug '17 News
BRIEF-Jenburkt Pharmaceuticals gets members' nod for re-appointment of Ashish Bhuta as chairman and MD
1st Aug '17 News
BRIEF-Jenburkt Pharma Dec-qtr profit falls
31st Jan '17 News
BRIEF-Jenburkt Pharmaceuticals June-qtr profit falls
27th Jul '16 News
© Stockopedia 2021, Refinitiv, Share Data Services.
Youtube Instagram RSS
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.